Medinet Co

2 Decision Makers · 2 Verified Contacts

📍 Kahoku, Miyagi, JapanBiotechnology🗓 Est. 1995👥 51–100 employees

About Medinet Co

Cancer immuno-cell therapy is an advanced medical practice.

Leadership & Decision Makers

Contact details of 2 Medinet Co decision makers

Yoshiji Kimura

President and Chief Executive Officer

Kohji Egawa

Scientific Founder

General Emails

General company emails, e.g. customer support lines

    info@medinet-inc.co.jp

    General Inquiries

    ir@medinet-inc.co.jp

    Investor Relations

    general-e@medinet-inc.co.jp

    Unclassified inbox

    kondo-m@medinet-inc.co.jp

    Unclassified inbox

    izumi@medinet-inc.co.jp

    Unclassified inbox

    fujieda-n@medinet-inc.co.jp

    Unclassified inbox

Similar Companies like Medinet Co

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 29/07/2025

+81454780041

Kahoku, Miyagi, Japan

Specialization: Therapeutics,
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Founded Date: 1995
Company Type: For Profit
Stock Symbol: TYO:2370
Operating Status: Active
Investor Type: Corporate Venture Capital
Last Funding Type: Post-IPO Equity
Phone Number: +81454780041
Last Investment Activity: Sep 29, 2015
Investments Activity: Sep 29, 2015 Feb 1, 2012 Sep 30, 2008

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.